✦ LIBER ✦

Effects of Single IV Doses of BG9928, an Adenosine A1 Antagonist, in Patients with Heart Failure

✍ Scribed by Stephen Gottlieb; David DeNofrio; Stuart Russell; Ying Zuh; Scott Stecher; Barry Ticho; William Abraham

Book ID: 116338676
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 290 KB
Volume: 14
Category: Article
ISSN: 1532-8414
DOI: 10.1016/j.cardfail.2008.06.181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Multiple Oral Doses of an A1

Effects of Multiple Oral Doses of an A1 Adenosine Antagonist, BG9928, in Patients With Heart Failure: Results of a Placebo-Controlled, Dose-Escalation Study

✍ Barry Greenberg; Ignatius Thomas; Dorothy Banish; Steven Goldman; Edward Havrane 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Renal effects of BG9928, an A1 adenosine

Renal effects of BG9928, an A1 adenosine receptor antagonist, in rats and nonhuman primates

✍ Barry Ticho; Eric Whalley; Alan Gill; Frank Lutterodt; Xiaowei Jin; John Auchamp 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

Renal effects of BG9719, a specific A1 a

Renal effects of BG9719, a specific A1 adenosine receptor antagonist, in congestive heart failure

✍ Andrew A. Wolff; Sandra L. Skettino; Evan Beckman; Luiz Belardinelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

A 1 adenosine receptors mediate renal afferent arteriolar vasoconstriction when distal tubular Na + concentrations increase (tubuloglomerular feedback, TGF). A 1 adenosine receptor stimulation also increases both proximal and distal tubular Na + reabsorption. Thus, an A 1 adenosine receptor antagoni

Effects of BG9719 (CVT-124), an A1-Adeno

Effects of BG9719 (CVT-124), an A1-Adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure

✍ Stephen S Gottlieb; Sandra L Skettino; Andrew Wolff; Evan Beckman; Michael L Fis 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 158 KB

The Safety of an Adenosine A1-Receptor A

The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment

✍ Professor John R. Teerlink, Vicente J. Iragui, Jay P. Mohr, Peter E. Carson, Pau 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 191 KB

Pharmacokinetics (PK) of Adenosine A1 Re

Pharmacokinetics (PK) of Adenosine A1 Receptor Antagonist BG9928 in Healthy Subjects, Elderly Subjects, and Subjects with Severe Renal Insufficiency (SRI)

✍ Thomas C. Marbury; Barry Ticho; Scott Stecher; Ying Zhu; Suzanne K. Swan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB